Media

TRIANNI Signs Agreement with Magenta Therapeutics for Use of The Trianni Mouse

San Francisco, CA, USA., March 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

TRIANNI Signs Collaboration Agreement with Fred Hutchinson Cancer Research Center for use of The Trianni Mouse Platform

San Francisco, CA, USA, March 8, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has finalized a non-exclusive license agreement […]

Continue reading

GigaGen and Trianni Announce License Agreement for Discovery of Fully Human Immuno-Oncology Antibodies

Partnership leverages GigaGen’s industry-leading immune repertoire sequencing and expression technology and Trianni’s best-in-class human transgenic mouse platform. February 28, 2017– […]

Continue reading

TRIANNI Signs Agreement with Stanford University for Use of The Trianni Mouse in Vaccine Research

San Francisco, CA, USA., February 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen

San Francisco, CA, USA., February 15, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

ChemPartner and Trianni Announce Partnering Agreement

San Francisco, CA, USA., August 2, 2016 – Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical […]

Continue reading

TRIANNI Announces Issuance of Patent in China

San Francisco, CA, USA., June 9, 2016 – Trianni, Inc. is pleased to announce that a patent for the Trianni […]

Continue reading

TRIANNI Announces Partnering Agreement with Evotec

San Francisco, CA, USA., May 17, 2016 – Trianni, Inc. (“TRIANNI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: […]

Continue reading

TRIANNI and LakePharma Announce Strategic Technology Partnering Agreement

San Francisco and Belmont, CA, USA, {May 9, 2016} – Trianni, Inc., (TRIANNI)  a private biotech company developing novel antibody […]

Continue reading

TRIANNI Announces Issuance of Russian Federation Patent

SAN FRANCISCO, March 2, 2016 — Trianni, Inc. (TRIANNI) announces that key aspects of its human antibody mouse platform were issued […]

Continue reading